January 29, 2019

Precision Medicine World Conference 2019 Takeaways

“We talk about technology a lot, but let’s remember why we’re here—to create precise solutions to meet patient needs.”  William Dalton, during the AI fireside chat.   The global BlueBee team joined for PMWC 2019 in Santa Clara, CA. Nearly 2,000 leaders across multiple domains—molecular and data scientists, bioinformaticians, IT...
Read more
October 14, 2018

ASHG Is Upon Us!

We hope to see you at ASHG! This year’s annual ASHG meeting, the largest human genetics conference, comes at the perfect time for us following recent activities and announcements, now culminating in this upcoming conference: We partnered with New England Biolabs to deliver an End-to-End Data Analysis solution for NEBNext...
Read more
July 18, 2018

England Reaches a Genomics Milestone with Routine DNA testing Across the Country

A huge leap forward has occurred in precision medicine: NHS cancer and other disease patients in England will be offered routine genomic testing starting as early as October of this year. This is the first health service of this kind, being offered in the world and is being built on...
Read more
March 15, 2018

Data Analysis, Aggregation And Management Have an Essential Role to Play in Gaining Insights and Wisdom From Genomic Data

Precision Medicine Forum Editor Mark Glover spoke to the BlueBee’s CEO Hans Cobben (pictured) about enabling and facilitating the potential of precision medicine through data analysis. BlueBee offers an advanced global bio-informatics platform to analyse, share and store genomics data. It supports users in clinical diagnostics, pharma and research with advanced analytics...
Read more
December 7, 2017

BlueBee adds NEN 7510:2011 Certification to its Security Portfolio

Read more
November 16, 2017

SLAMdunk – Another Optimized Lexogen, BlueBee Pipeline to Simplify Data Analysis

In September this year, Lexogen released the family of SLAMseq Metabolic RNA labeling kits, the underlying methodology of which is based on S4U labeling of RNA in cell cultures, alkylation of RNA with iodoacetamide, and the consequent introduction of T to C mutations in cDNA. To simplify the data analysis component...
Read more
November 6, 2017

Overcoming High Sequence Complexity with the PacBio De Novo Assembly Pipeline, on the BlueBee Platform

Complex elements – repetitive regions, copy number variants, or structural variations – are challenging, if not impossible to sequence using short-read technologies. PacBio’s long-read technology based on Single Molecule, Real-Time (SMRT) sequencing, delivers long reads with uniform coverage, allowing comprehensive de novo genome assemblies that can overcome the short-read sequencing...
Read more
November 3, 2017

ASHG 2017 was all About Expediting the Analysis and Interpretation of Research and Clinical Data

The theme of this year’s annual gathering of geneticists at the American Society of Human Genetics conference held in Orlando was centered around expediting the analysis and interpretation of both research and clinical data. The conference kicked off with a talk by ASHG President Dr. Nancy Cox, highlighting the need for...
Read more
October 9, 2017

Join the BlueBee and PacBio® expert hours at ASHG

At this year’s gathering of human geneticists at ASHG, BlueBee will seize the opportunity to highlight our latest developments and our newly established collaboration with PacBio, making their “de novo sequencing pipeline” instantly accessible for BlueBee users. This HGAP4 pipeline simplifies the workflow and offers a fully automated, end-to-end, data...
Read more
September 26, 2017

Homing in on Clinically Relevant Variants with the BlueBee Annotation Reference Pipeline

Read more
Request A Demo